TOLDBODGADE 33, 1253 COPENHAGEN K, G7
Market cap: $18.8B (2/09/2026)
Price: $30.60
Reports Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16
Grant of Restricted Stock Units and Warrants to Employees in Announcement
Announces Net Sales of DARZALEX® (daratumumab) for 2025
Portfolio Prioritization Update
Announces Completion of Tender Offer for Outstanding Common Shares of N.V. and Commencement of Subsequent Offering Period
Transactions With Shares and Linked Securities Made by Managerial Employees and Their Closely Associated Persons
Reports Foreign Private Issuer Information for November 2025
Annual and Transition Report of Foreign Private Issuers
Tender Offer Statement by Third Party
Tender Offer Statement by Issuer
Effectiveness Notice
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(4)
No filings found
Statement of Changes in Beneficial Ownership
Amended Schedule 13D - Ownership Report
Schedule 13D - Ownership Report
Initial Statement of Beneficial Ownership
Schedule 13G - Ownership Report
Amended Tender Offer Statement by Third Party
Registration Statement for Depositary Shares
Registration Statement for Depositary Shares, Issued upon Effectiveness
Registration Statement for Additional Securities of Certain Foreign Private Issuers, Filed Pursuant to Rule 462(b)